CAM
Cormorant Asset Management’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.69M | Hold |
175,000
| – | – | 0.42% | 36 |
|
|
2025
Q1 | $6.61M | Sell |
175,000
-250,000
| -59% | -$9.44M | 0.5% | 35 |
|
|
2024
Q4 | $34.8M | Sell |
425,000
-575,000
| -58% | -$47.1M | 1.91% | 14 |
|
|
2024
Q3 | $114M | Sell |
1,000,000
-100,000
| -9% | -$11.4M | 6.06% | 2 |
|
|
2024
Q2 | $83.1M | Buy |
1,100,000
+415,000
| +61% | +$31.3M | 4.8% | 4 |
|
|
2024
Q1 | $46.8M | Buy |
685,000
+20,000
| +3% | +$1.37M | 2.05% | 14 |
|
|
2023
Q4 | $41.8M | Hold |
665,000
| – | – | 1.99% | 14 |
|
|
2023
Q3 | $33.9M | Hold |
665,000
| – | – | 1.98% | 13 |
|
|
2023
Q2 | $33.2M | Buy |
665,000
+390,000
| +142% | +$19.5M | 1.86% | 11 |
|
|
2023
Q1 | $10.3M | Sell |
275,000
-50,000
| -15% | -$1.87M | 0.68% | 38 |
|
|
2022
Q4 | $15.6M | Buy |
+325,000
| New | +$15.6M | 1.04% | 31 |
|